Participate in Research      Email list for events
I prefer to be contacted by:  Phone      Email
What is the best time to contact you?: 
 
  Research Site Selection Criteria

Genetic Components of Autism and Related Disorders

Linda Brzustowicz (PI)
Judy Flax (Co-I)
[Rutgers University]

brzustowicz@biology.rutgers.edu
(848) 445-3331

145 Bevier Road
Piscataway, NJ 08854

Families are encouraged to participate if they:

  • Have at least one family member with an autism spectrum disorder and language impairment 
  • Have at least one other family member with a language-based learning disability
  • Have at least 5 participating family members that speak English
  • Have all family members willing to give a blood sample for genetic analysis

Paratransit Travel and Mobility Assessment

Cecilia Feeley (PI)
[Rutgers University]

cfeeley@rci.rutgers.edu
(848) 445-2975

100 Brett Road
Piscataway, NJ 08854

  • Do you have autism spectrum disorder?
  • Are you 18 years or older?
  • Do you live in New Jersey?
  • Would you be interested in riding  Access Link or other county paratransit  services if you could? 

Can video speak the language of Autism?

Amy Learmonth (PI)
[William Paterson University]

learmontha@wpunj.edu
(973) 720-2765

300 Pompton Road
Wayne, NJ 07470

We are testing both typically developing children and children with Autism between the ages of 36 and 48 months.
https://www.youtube.com/v/_PoD6bJ6pIk 


Failed to Upload Picture

Sulforaphane in autism.

William Johnson (PI)
Edward (Scot) Strenos (Proj Coord)
[Rutgers University]

stenroos@rutgers.edu
(732) 235-5490

661 Hoes Lane West
Piscataway, NJ 08854

  • Males ages 13-30 years of age with Autistic Disorder diagnosis.

Using SMART Treatment Design to Evaluate ABA Interventions

Mary Louise E. Kerwin (PI)
Michelle Soreth (Co-PI)
[Rowan University]

kerwin@rowan.edu
(856) 256-4821

201 Mullica Hill Road
Glassboro, NJ 08028

Inclusion Criteria

  1. Previous clinical diagnosis of ASD based on DSM-V which is confirmed via scores on ADOS-2.
  2. Between the ages of 2 and 5 years.
  3. Receptive language age of at least 12 months on the MSEL
  4. Minimum of at least 2 spoken words during the administration of the ADOS-2
  5. Parent/guardian is willing to transport the child to intervention sessions at Rowan University
  6. English Speaking
  7. Parent/Guardian agrees not to start any new therapies during the 4 months of the study without speaking to PI first
  8. Parent/Guardian is willing to allow therapist-child and novel adult-child interaction assessment sessions to be video recorded and to complete assessment batteries at 8-weeks and 4-months.

Exclusion Criteria

  1. Medical histories and/or physical examination indicating physical or sensory impairments or significant medical problems (e.g., seizure disorders) that would interfere with learning.
  2. Exhibits severe aggression or self-injurious behavior

Failed to Upload Picture

Experiences of families of children newly diagnosed with ASD

Deborah Spitalnik (PI)
Caroline Coffield (Co-I)
[Boggs Center for Developmental Disabilities ]

deborah.spitalnik@rutgers.edu
(732) 235-9326

335 George Street
New Brunswick, NJ 08902

Latino families of children newly diagnosed with ASD


  • English or Spanish speaking
  •  with a child between the ages of 18 months and 5 years

Development of Early Markers of ASD

Michael Lewis (PI)
Nicholas Minar (Co-I)
[Rutgers University]

lewis@rwjms.rutgers.edu
(732) 235-7700

89 French Street
New Brunswick, NJ 08901

Infants and toddlers between the ages of 3 months and 24 months

  • typically developing or
  • at-risk (older sibling diagnosed with ASD)

Failed to Upload Picture

Bridging behavior and genetics

Elizabeth Torres (PI)
Caroline Whyatt (Co-PI)
[Rutgers University]

ebtorres@rci.rutgers.edu
(848) 445-8909

152 Frelinghuysen Rd
Piscataway, NJ 08854

  • individuals with autism and their immediate family members
  • individuals with autism related to the Fragile-X mental retardation gene FMR1, both individuals with a diagnosis of autism with the full mutation (Fragile-X syndrome, FXS) and those who are carriers
  • neurotypical individuals and their family members

Doctors Jyonouchi (standing) and Lee (seated)

Autism Spectrum Disorder-Inflammatory Subtype: Biomarker Analysis

Harumi Jyonouchi (PI)
[Saint Peter's University Hospital]

hjyonouchi@saintpetersuh.com
(732) 339-7780

254 Easton Avenue, 3rd Floor MOB
New Brunswick, NJ 08901

  • ASD subjects diagnosed within 12 mo (Age 2-6 years)
  • ASD subjects with established ASD diagnosis (Age 7-31 years)